Global Neurodegenerative Disease Market Size, Share, and COVID-19 Impact Analysis, By Disease (Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis), By Route of Administration (Oral, Injectable, Transdermal, and Others), By Drug (Cholinesterase Inhibitors, Gene Therapy, NMDA Receptor Antagonists, and Dopaminergic Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare
RELEASE DATE Mar 2025
REPORT ID SI6509
PAGES 255
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Disease
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Drug
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Neurodegenerative diseases are influenced by aging, genetic predisposition
    3. Restraints
      1.  High cost, and limited treatment efficacy
    4. Opportunities
      1.  Rising prevalence, advancements in disease-modifying therapies
    5. Challenges
      1. Neurodegenerative diseases face challenges due to their complexity
  6. Global Neurodegenerative Disease Market Analysis and Projection, By Disease
    1. Segment Overview
    2. Alzheimer’s Disease
    3. Parkinson’s Disease
    4. Huntington’s Disease
    5. Multiple Sclerosis
  7. Global Neurodegenerative Disease Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Injectable
    4. Transdermal
    5. Others
  8. Global Neurodegenerative Disease Market Analysis and Projection, By Drug
    1. Segment Overview
    2. Cholinesterase Inhibitors
    3. Gene Therapy
    4. NMDA Receptor Antagonists
    5. Dopaminergic Drugs
  9. Global Neurodegenerative Disease Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Neurodegenerative Disease Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Neurodegenerative Disease Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Biogen Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Roche Holding AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novartis AG 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  AstraZeneca plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Bristol-Myers Squibb
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Merck & Co., Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  AbbVie Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Amgen Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Sanofi S.A.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Takeda Pharmaceutical Company Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Teva Pharmaceutical Industries Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Neurocrine Biosciences, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  2. Global Alzheimer’s Disease, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  3. Global Parkinson’s Disease, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  4. Global Huntington’s Disease, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  5. Global Multiple Sclerosis, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  6. Global Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  7. Global Oral, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  8. Global Injectable, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  9. Global Transdermal, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  10. Global Others, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  11. Global Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  12. Global Cholinesterase Inhibitors, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  13. Global Gene Therapy, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  14. Global NMDA Receptor Antagonists, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  15. Global Dopaminergic Drugs, Neurodegenerative Disease Market, By Region, 2023-2033(USD Billion)
  16. North America Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  17. North America Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  18. North America Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  19. U.S.  Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  20. U.S.  Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  21. U.S.  Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  22. Canada Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  23. Canada Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  24. Canada Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  25. Mexico Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  26. Mexico Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  27. Mexico Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  28. Europe Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  29. Europe Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  30. Europe Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  31. Germany Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  32. Germany Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  33. Germany Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  34. France Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  35. France Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  36. France Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  37. U.K.  Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  38. U.K.  Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  39. U.K.  Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  40. Italy Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  41. Italy Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  42. Italy Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  43. Spain Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  44. Spain Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  45. Spain Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  46. Asia Pacific Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  47. Asia Pacific Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  48. Asia Pacific Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  49. Japan Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  50. Japan Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  51. Japan Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  52. China Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  53. China Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  54. China Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  55. India Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  56. India Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  57. India Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  58. South America Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  59. South America Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  60. South America Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  61. Brazil Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  62. Brazil Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  63. Brazil Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  64. The Middle East and Africa Neurodegenerative Disease Market, By Disease, 2023-2033(USD   Billion)
  65. The Middle East and Africa Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD   Billion)
  66. The Middle East and Africa Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  67. UAE Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  68. UAE Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  69. UAE Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)
  70. South Africa Neurodegenerative Disease Market, By Disease, 2023-2033(USD Billion)
  71. South Africa Neurodegenerative Disease Market, By Route of Administration, 2023-2033(USD Billion)
  72. South Africa Neurodegenerative Disease Market, By Drug, 2023-2033(USD Billion)

List of Figures 

  1. Global Neurodegenerative Disease Market Segmentation
  2. Neurodegenerative Disease Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Neurodegenerative Disease Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Neurodegenerative Disease Market
  20. Neurodegenerative Disease Market Segmentation, By Disease
  21. Neurodegenerative Disease Market For Alzheimer’s Disease, By Region, 2023-2033 ($ Billion)
  22.  Neurodegenerative Disease Market For Parkinson’s Disease, By Region, 2023-2033 ($ Billion)
  23. Neurodegenerative Disease Market For Huntington’s Disease, By Region, 2023-2033 ($ Billion)
  24. Neurodegenerative Disease Market For Multiple Sclerosis, By Region, 2023-2033 ($ Billion)
  25.  Neurodegenerative Disease Market Segmentation, By Route of Administration
  26.  Neurodegenerative Disease Market For Oral, By Region, 2023-2033 ($ Billion)
  27.  Neurodegenerative Disease Market For Injectable, By Region, 2023-2033 ($ Billion)
  28. Neurodegenerative Disease Market For Transdermal, By Region, 2023-2033 ($ Billion)
  29. Neurodegenerative Disease Market For Others, By Region, 2023-2033 ($ Billion)
  30. Neurodegenerative Disease Market Segmentation, By Drug
  31. Neurodegenerative Disease Market For Cholinesterase Inhibitors, By Region, 2023-2033 ($ Billion)
  32. Neurodegenerative Disease Market For Gene Therapy, By Region, 2023-2033 ($ Billion)
  33. Neurodegenerative Disease Market For NMDA Receptor Antagonists, By Region, 2023-2033 ($ Billion)
  34. Neurodegenerative Disease Market For Dopaminergic Drugs, By Region, 2023-2033 ($ Billion)
  35. Biogen Inc.: Net Sales, 2023-2033 ($ Billion)
  36. Biogen Inc.: Revenue Share, By Segment, 2023 (%)
  37. Biogen Inc.: Revenue Share, By Region, 2023 (%)
  38. Eli Lilly and Company: Net Sales, 2023-2033 ($ Billion)
  39. Eli Lilly and Company: Revenue Share, By Segment, 2023 (%)
  40. Eli Lilly and Company: Revenue Share, By Region, 2023 (%)
  41. Roche Holding AG: Net Sales, 2023-2033 ($ Billion)
  42. Roche Holding AG: Revenue Share, By Segment, 2023 (%)
  43. Roche Holding AG: Revenue Share, By Region, 2023 (%)
  44. Novartis AG: Net Sales, 2023-2033 ($ Billion)
  45. Novartis AG: Revenue Share, By Segment, 2023 (%)
  46. Novartis AG: Revenue Share, By Region, 2023 (%)
  47. Pfizer Inc.: Net Sales, 2023-2033 ($ Billion)
  48. Pfizer Inc.: Revenue Share, By Segment, 2023 (%)
  49. Pfizer Inc.: Revenue Share, By Region, 2023 (%)
  50. AstraZeneca plc: Net Sales, 2023-2033 ($ Billion)
  51. AstraZeneca plc: Revenue Share, By Segment, 2023 (%)
  52. AstraZeneca plc: Revenue Share, By Region, 2023 (%)
  53. Bristol-Myers Squibb: Net Sales, 2023-2033 ($ Billion)
  54. Bristol-Myers Squibb: Revenue Share, By Segment, 2023 (%)
  55. Bristol-Myers Squibb: Revenue Share, By Region, 2023 (%)
  56. Merck & Co., Inc.: Net Sales, 2023-2033 ($ Billion)
  57. Merck & Co., Inc.: Revenue Share, By Segment, 2023 (%)
  58. Merck & Co., Inc.: Revenue Share, By Region, 2023 (%)
  59. AbbVie Inc..: Net Sales, 2023-2033 ($ Billion)
  60. AbbVie Inc..: Revenue Share, By Segment, 2023 (%)
  61. AbbVie Inc..: Revenue Share, By Region, 2023 (%)
  62. Amgen Inc.: Net Sales, 2023-2033 ($ Billion)
  63. Amgen Inc.: Revenue Share, By Segment, 2023 (%)
  64. Amgen Inc.: Revenue Share, By Region, 2023 (%)
  65. Sanofi S.A.: Net Sales, 2023-2033 ($ Billion)
  66. Sanofi S.A.: Revenue Share, By Segment, 2023 (%)
  67. Sanofi S.A.: Revenue Share, By Region, 2023 (%)
  68. Takeda Pharmaceutical Company Limited: Net Sales, 2023-2033 ($ Billion)
  69. Takeda Pharmaceutical Company Limited: Revenue Share, By Segment, 2023 (%)
  70. Takeda Pharmaceutical Company Limited: Revenue Share, By Region, 2023 (%)
  71. Teva Pharmaceutical Industries Ltd.: Net Sales, 2023-2033 ($ Billion)
  72. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2023 (%)
  73. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2023 (%)
  74. Neurocrine Biosciences, Inc.: Net Sales, 2023-2033 ($ Billion)
  75. Neurocrine Biosciences, Inc.: Revenue Share, By Segment, 2023 (%)
  76. Neurocrine Biosciences, Inc.: Revenue Share, By Region, 2023 (%)
  77. Others: Net Sales, 2023-2033 ($ Billion)
  78. Others: Revenue Share, By Segment, 2023 (%)
  79. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:121
Pages:255
Countries covered:17
Companies covered::20
Forecast CAGR:7.84%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies